Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies

With the development of anti-tumor drugs, tyrosine kinase inhibitors (TKIs) are an indispensable part of targeted therapy. They can be superior to traditional chemotherapeutic drugs in selectivity, safety, and efficacy. However, they have been found to be associated with serious adverse effects in u...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mengfei Cheng, Fang Yang, Jiahui Liu, Dan Yang, Shuo Zhang, Yang Yu, Shuai Jiang, Mei Dong
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/55ad76f9d3e0435eaee247780c1c1fba
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!